Case Report : Generalized Myasthenia Gravis
DOI:
https://doi.org/10.19166/med.v7i5.2497Keywords:
Myasthenia Gravis, GeneralizedAbstract
Generalized myasthenia gravis is a rare case of autoimmune wherein the antibodies destroy the post-sinaptic acetylcholine receptors at skeletal muscle’s neuromuscular junctions. The clinical presentation is specific distributin of motoric deficit without sensoric deficit which diminished with rest and worsens with excessive use. We report a case of a woman 52 yo with symptoms of ptosis, diplopia and dificulty of swallowing. Repetitive nerve stimulation showed >10% decrement and prostigmin test was positive. The patient was treated and showed clinical improvement.References
Anindhita T, Wiratman W. Buku Ajar Neurologi : Buku 2. 2014. Jakarta : Badan Penerbit Fakultas Kedokteran Universitas Indonesia. h 741-54.
Hauser SL, Josephson SA. Harrison’s Neurology in Clinical Medicine 2nd Ed. 2010. United States : McGraw Hill. H 559-567.
Liu WW, Chen A. Diagnosing Myasthenia Gravis with an Ice Pack. NEJM. 2016. 375 : 19.
Burns TM, Conaway M, Sanders DB. The MG Composite : A Valid and Reliable Outcome Measure for Myasthenia Gravis. Neurology. 2010. 74:1434-40.
N Wakata, H Nermoto, S Konno, et al. Myasthenia Gravis and Diabetes Mellitus : A 35-Year Retrospective Study. Intern Med. 2007; 46(9): 557-9.
Puneeth CS, Chandra SR, Chandran S. Heart Rate and Blood Pressure Variability in Patient with Myasthenia Gravis. Ann Indian Acad of Neurol. 2013; 16(3): 329-332.
Wolfe GI, Kaminski HJ, Aban IB, et al. Randomized Trial of Thymectomy in Myasthenia Gravis. NEJM. 2016. 376: (6): 511-22.
Sussman J, Farrugia ME, Maddison P, et al. Myasthenia Gravis : Association of British Neurologists’ Management Guidelines. Pract Neurol. 2015;15:199-206.
Sanders DB, Wolfe GI, Benatar M, et al. International Consensus Guidance for Management of Myasthenia Gravis. Neurology. 2016; 87 : 350.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.